Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Jun 27;3(5):585-594.
doi: 10.1002/bjs5.50179. eCollection 2019 Oct.

Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy

S Hallam  1 , R Tyler  1 , M Price  2 , A Beggs  1 , H Youssef  3
Affiliations
Meta-Analysis

Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy

S Hallam et al. BJS Open. .

Abstract

Background: Up to 15 per cent of colorectal cancers present with peritoneal metastases (CPM). Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS + HIPEC) aims to achieve macroscopic tumour resection combined with HIPEC to destroy microscopic disease. CRS + HIPEC is a major operation with significant morbidity and effects on quality of life (QoL). Improving patient selection is crucial to maximize patient outcomes while minimizing morbidity and mortality. The aim of this study was to identify prognostic factors for patients with CPM undergoing CRS + HIPEC.

Methods: A systematic search of MEDLINE, Embase and Cochrane Library electronic databases was performed using terms for colorectal cancer, peritoneal metastasis and CRS + HIPEC. Included studies focused on the impact of prognostic factors on overall survival following CRS + HIPEC in patients with CPM.

Results: Twenty-four studies described 3128 patients. Obstruction or perforation of the primary tumour (hazard ratio (HR) 2·91, 95 per cent c.i. 1·5 to 5·65), extent of peritoneal metastasis as described by the Peritoneal Carcinomatosis Index (PCI) (per increase of 1 PCI point: HR 1·07, 1·02 to 1·12) and the completeness of cytoreduction (CC score above zero: HR 1·75, 1·18 to 2·59) were associated with reduced overall survival after CRS + HIPEC.

Conclusion: Primary tumour obstruction or perforation, PCI score and CC score are valuable prognostic factors in the selection of patients with CPM for CRS + HIPEC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA diagram for the review CENTRAL, Cochrane Central Register of Controlled Trials; CDSR, Cochrane Database of Systematic Reviews; DARE, Database of Abstracts of Reviews of Effects; HIPEC, heated intraperitoneal chemotherapy; CRS, cytoreductive surgery; PFS, progression‐free survival; DFS, disease‐free survival.
Figure 2
Figure 2
Effect of prognostic factors on overall survival Hazard ratios are shown with 95 per cent confidence intervals. Values in parentheses after each factor indicate the numbers of studies providing unadjusted and adjusted hazard ratios respectively. ECOG, Eastern Cooperative Oncology Group; PM, peritoneal metastasis; GI, gastrointestinal; PCI, Peritoneal Carcinomatosis Index; CC, completeness of cytoreduction.
See this image and copyright information in PMC

References

    1. Jayne DG, Fook S, Loi C, Seow‐Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1545–1550. - PubMed
    1. Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg 2012; 99: 699–705. - PubMed
    1. Quere P, Facy O, Manfredi S, Jooste V, Faivre J, Lepage C et al Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population‐based study. Dis Colon Rectum 2015; 58: 743–752. - PubMed
    1. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989; 63: 364–367. - PubMed
    1. Klaver YL, Simkens LH, Lemmens VE, Koopman M, Teerenstra S, Bleichrodt RP et al Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol 2012; 38: 617–623. - PubMed

MeSH terms